751 results
Page 5 of 38
6-K
EX-99.1
6z9g337i4a9cdc7z
20 Oct 16
Live Filing
12:00am
6-K
EX-99.1
03rfw8b3ku
6 Oct 16
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
12:00am
6-K
EX-99.1
vj30e
20 Sep 16
Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic Pain
12:00am
6-K
EX-99.1
bhaftnx
18 Aug 16
First Intravenous Anti-IL-5 Biologic Therapy for Severe Eosinophilic Asthma Now Approved in Europe
12:00am
6-K
zdxox
20 Jul 16
Current report (foreign)
12:00am
424B5
cbuzcg
18 Jul 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
nndukwvssy8j6idzfc
10 Jun 16
Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement Litigation
12:00am
6-K
EX-99.1
zzhzd
18 Apr 16
First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809
12:00am
6-K
EX-99.1
wxtox51
12 Apr 16
Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual Meeting
12:00am
424B5
3gqc8d44atzhe
30 Nov 15
Prospectus supplement for primary offering
12:00am
424B5
od9oton
30 Nov 15
Prospectus supplement for primary offering
12:00am
6-K
c5w3y4s
30 Nov 15
Current report (foreign)
12:00am
6-K
79mkldq9 q7
30 Nov 15
Current report (foreign)
12:00am
6-K
EX-99.1
5bx74fraxg3o
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
u90rl49w5fc
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am
6-K
EX-99.1
erj2mh7r21euj v0jp5
28 Sep 15
Teva Announces Approval of COPAXONE® in Japan for the Prevention of Relapse of Multiple Sclerosis
12:00am
6-K
EX-99.3
fnepaa3662qds3 wnbz
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
6-K
EX-99.1
jyfgt7p25r 1c3lu
23 Mar 15
Live Filing
12:00am
6-K
EX-99.1
j5v9h
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am